7-ethylcamptothecin has been researched along with Leukemia L 1210 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furuta, T; Miyasaka, T; Sawada, S; Yaegashi, T; Yokokura, T | 1 |
| Baba, H; Kunimoto, T; Miyasaka, T; Mutai, M; Nitta, K; Sawada, S; Takeuchi, M; Tanaka, T; Uehara, N; Yokokura, T | 2 |
| Fukada, M; Furuta, T; Kaneda, N; Miyasaka, T; Nagata, H; Notake, K; Sawada, S; Yokokura, T | 1 |
4 other study(ies) available for 7-ethylcamptothecin and Leukemia L 1210
| Article | Year |
|---|---|
Chemical modification of an antitumor alkaloid, 20(S)-camptothecin: E-lactone ring-modified water-soluble derivatives of 7-ethylcamptothecin.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Lactones; Leukemia L1210; Mice; Solubility; Water | 1993 |
[Antitumor activity of new derivatives of camptothecin].
Topics: Animals; Antineoplastic Agents; Camptothecin; Doxorubicin; Irinotecan; Lethal Dose 50; Leukemia L1210; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred ICR; Neoplasms, Experimental | 1987 |
Antitumor activity of a new camptothecin derivative, SN-22, against various murine tumors.
Topics: Animals; Antineoplastic Agents; Camptothecin; Lethal Dose 50; Leukemia L1210; Mice; Mice, Inbred Strains; Neoplasms, Experimental | 1987 |
Action of 7-ethylcamptothecin on tumor cells and its disposition in mice.
Topics: Animals; Camptothecin; Cell Cycle; Cell Division; Chromatography, High Pressure Liquid; Female; Flow Cytometry; Kinetics; Leukemia L1210; Mice; Tissue Distribution | 1987 |